Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis

Authors

  • Gil Yosipovitch
  • Yan Dong
  • Russel Burge
  • Baojin Zhu
  • David Shrom
  • Alexa B. Kimball

DOI:

https://doi.org/10.2340/00015555-3254

Keywords:

Ixekizumab: quality-of-life, moderate-to-severe psoriasis, Itch, PASI, DLQI

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2019-07-17

How to Cite

Yosipovitch, G., Dong, Y., Burge, R., Zhu, B., Shrom, D., & Kimball, A. B. (2019). Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis. Acta Dermato-Venereologica, 99(11), 1031–1032. https://doi.org/10.2340/00015555-3254

Issue

Vol. 99 No. 11 (2019): October

Section

Short Communication

License

Copyright (c) 2019 Gil Yosipovitch, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, Alexa B. Kimball

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC